Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

0.6174
-0.5176-45.60%
Pre-market: 0.5926-0.0248-4.02%04:52 EDT
Volume:37.51M
Turnover:23.23M
Market Cap:66.06M
PE:-0.57
High:0.6700
Open:0.6360
Low:0.5460
Close:1.14
52wk High:3.54
52wk Low:0.5460
Shares:107.00M
Float Shares:102.16M
Volume Ratio:18.97
T/O Rate:36.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0751
EPS(LYR):-1.5900
ROE:-78.27%
ROA:-36.84%
PB:0.67
PE(LYR):-0.39

Loading ...

Jul 18, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jul 15, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
Jun 01, 2022

Major Issues Report

8-K - Current report
Jun 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 12, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2022

Major Issues Report

8-K - Current report
Mar 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 21, 2022

Major Issues Report

8-K - Current report
Mar 21, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities